Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance

Abstract

In a high-income setting, we found a 12-month (H)RfZE regimen with a short Z duration to be similarly effective for Hr tuberculosis with or without a Fq. This regimen may result in fewer adverse events than the WHO recommendations.